PACB PACIFIC BIOSCIENCES CALIF IN

Ownership history in Man Group plc  ·  14 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in PACIFIC BIOSCIENCES CALIF IN (PACB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2023 Q3)
Avg. % of fund
0.01%
First filed
2019 Q1
Last filed
2025 Q3
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 250,276 +218,776 +694.5% 0.00% $320K $1.28
2024 Q1 REDUCED 31,500 -4,501 -12.5% 0.00% $118K $3.75
2023 Q4 REDUCED 36,001 -1,347,677 -97.4% 0.00% $353K $9.81
2023 Q3 ADDED 1,383,678 +900,098 +186.1% 0.04% $11.6M $8.35
2023 Q2 ADDED 483,580 +460,614 +2005.6% 0.02% $6.4M $13.30
2022 Q2 ADDED 22,966 +10,255 +80.7% 0.00% $102K $4.42
2021 Q2 REDUCED 12,711 -149,350 -92.2% 0.00% $444K $34.97
2021 Q1 REDUCED 162,061 -91,521 -36.1% 0.02% $5.4M $33.31
2020 Q4 ADDED 253,582 +228,267 +901.7% 0.03% $6.6M $25.94
2020 Q2 REDUCED 25,315 -760,531 -96.8% 0.00% $87K $3.45
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PACB price (monthly, adj. close)
← Back to Man Group plc Holdings